会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Method and System to Adjust Pacing Parameters Based on Systolic Interval Heart Sounds
    • 基于收缩期间心脏声音调整起搏参数的方法和系统
    • US20130053913A1
    • 2013-02-28
    • US13223117
    • 2011-08-31
    • Steve KohGene A. BornzinJeffery D. Snell
    • Steve KohGene A. BornzinJeffery D. Snell
    • A61N1/368
    • A61N1/368A61B7/00A61B7/04A61N1/36585
    • A method is provided to determine pacing parameters for an implantable medical device (IMD) and collects heart sounds during the cardiac cycles. The method comprises changing a value for a pacing parameter between the cardiac cycles and analyzing a characteristic of interest from the heart sounds. The method comprises setting a desired value for the pacing parameter based on the characteristic of interest from the heart sounds. The system comprises inputs configured to be coupled to at least one lead having electrodes to sense intrinsic events and to deliver pacing pulses over cardiac cycles. The system has a sensor for collecting heart sounds during cardiac cycles and controller to control delivery of pacing pulses based on pacing parameters. The controller changes a value for at least one of the pacing parameters between the cardiac cycles and provides an analysis module to analyze a characteristic of interest from the heart sounds.
    • 提供了一种用于确定可植入医疗装置(IMD)的起搏参数并在心脏周期期间收集心脏声音的方法。 该方法包括在心脏周期之间改变起搏参数的值并且从心脏声音分析感兴趣的特征。 该方法包括基于来自心音的感兴趣的特征来设置起搏参数的期望值。 该系统包括被配置为耦合到具有电极以感测固有事件并且在心动周期上传送起搏脉冲的至少一个引线的输入。 该系统具有用于在心动周期期间收集心脏声音的传感器和控制器,以根据起搏参数控制起搏脉冲的传递。 控制器改变心脏周期之间的至少一个起搏参数的值,并提供分析模块来分析来自心脏声音的兴趣特征。
    • 5. 发明授权
    • Identifying left atrial pressure elevation by means of a respiratory component
    • 通过呼吸成分识别左心房压力升高
    • US08343059B1
    • 2013-01-01
    • US11678401
    • 2007-02-23
    • Steve Koh
    • Steve Koh
    • A61B5/02A61B5/08
    • A61B5/686A61B5/0205A61B5/0215
    • A signal indicative of left atrial pressure in the heart of a patient is analyzed to identify a signal component that is related to the respiration of the patient. An indication relating to the left atrial pressure may be generated based on the presence, absence, or magnitude of the respiratory component. In some embodiments the indication may be used to indicate high left atrial pressure. In some embodiments the indication may be used to indicate heart failure. In some embodiments the indication may be used in conjunction with verifying the operation of a left atrial pressure sensor. In the event of high left atrial pressure or an incorrect pressure reading an appropriate warning may be generated. In the event of an incorrect pressure reading the left atrial pressure sensor may be recalibrated.
    • 分析指示患者心脏中的左心房压力的信号以识别与患者的呼吸相关的信号分量。 可以基于呼吸成分的存在,不存在或大小产生与左心房压力有关的指示。 在一些实施例中,该指示可用于指示高的左心房压力。 在一些实施例中,该指示可用于指示心力衰竭。 在一些实施例中,指示可以与验证左心房压力传感器的操作结合使用。 在左心房压力高或压力读数不正确的情况下,可能会产生适当的警告。 在压力读数不正确的情况下,可以重新校准左心房压力传感器。
    • 6. 发明授权
    • Implantable systems and methods for monitoring BNP levels, HF and MI
    • 用于监测BNP水平,HF和MI的植入式系统和方法
    • US08326422B2
    • 2012-12-04
    • US12341074
    • 2008-12-22
    • Allen KeelSteve KohTaraneh Ghaffari Farazi
    • Allen KeelSteve KohTaraneh Ghaffari Farazi
    • A61N1/00
    • A61N1/3627A61B5/024A61B5/0452A61B5/0464A61B5/053A61B5/145A61N1/36557A61N1/36585A61N1/37258
    • Methods for monitoring a patient's level of B-type natriuretic peptide (BNP), and implantable cardiac systems capable of performing such methods, are provided. A ventricle is paced for a period of time to provoke a ventricular evoked response, and a ventricular intracardiac electrogram (IEGM) indicative of the ventricular evoked response is obtained. Based on the ventricular IEGM, there is a determination of at least one ventricular evoked response metric (e.g., ventricular evoked response peak-to-peak amplitude, ventricular evoked response area and/or ventricular evoked response maximum slope), and the patient's level of BNP is monitored based on determined ventricular evoked response metric(s). Based on the monitored level's of BNP, the patients heart failure (HF) condition and/or risks and/or occurrences of certain events (e.g., an acute HF exacerbation and/or an acute myocardial infarction) can be monitored.
    • 提供了用于监测患者B型利钠肽(BNP)水平的方法,以及能够执行这些方法的可植入心脏系统。 心室起搏一段时间以引发心室诱发反应,并获得指示心室诱发反应的心室心内电图(IEGM)。 基于心室IEGM,确定至少一个心室诱发反应度量(例如,心室诱发反应峰 - 峰幅度,心室诱发反应面积和/或心室诱发反应最大斜率)和患者的水平 基于确定的心室诱发反应度量监测BNP。 基于监测的BNP水平,可以监测患者的心力衰竭(HF)状况和/或某些事件的风险和/或发生(例如急性HF急性发作和/或急性心肌梗塞)。
    • 7. 发明授权
    • System and method for identifying a potential cause of pulmonary edema
    • 识别肺水肿的潜在原因的系统和方法
    • US08323205B2
    • 2012-12-04
    • US12368916
    • 2009-02-10
    • Euljoon ParkSteve Koh
    • Euljoon ParkSteve Koh
    • A61B5/0205
    • A61B5/0537A61B5/4878A61N1/36521
    • A method of identifying a potential cause of pulmonary edema is provided. The method includes obtaining one or more impedance vectors between predetermined combinations of the electrodes positioned proximate the heart. At least one of the impedance vectors is representative of a thoracic fluid level. The method also includes applying a stimulation pulse to the heart and sensing cardiac signals of the heart that are representative of an electrophysiological response to the stimulation pulse. The method further includes monitoring the cardiac signals and at least one of the impedance vectors with respect to time to identify the potential cause of pulmonary edema.
    • 提供了鉴定肺水肿潜在原因的方法。 该方法包括在定位在心脏附近的电极的预定组合之间获得一个或多个阻抗矢量。 阻抗向量中的至少一个代表胸水液位。 该方法还包括向心脏施加刺激脉冲并感测代表对刺激脉冲的电生理响应的心脏心脏信号。 该方法还包括相对于时间监测心脏信号和阻抗向量中的至少一个以识别肺水肿的潜在原因。
    • 9. 发明申请
    • METHOD AND SYSTEM FOR DISCRIMINATING AND MONITORING ATRIAL ARRHYTHMIA BASED ON CARDIOGENIC IMPEDANCE
    • 基于心脏阻力的ATRIAL ARRHYTHMIA的辨别和监测方法与系统
    • US20120089032A1
    • 2012-04-12
    • US12901296
    • 2010-10-08
    • Euljoon ParkSteve KohGene A. Bornzin
    • Euljoon ParkSteve KohGene A. Bornzin
    • A61B5/042A61B5/0205
    • A61B5/046A61B5/0006A61B5/0031A61B5/02028A61B5/0205A61B5/029A61B5/0402A61B5/0422A61B5/0468A61B5/0538A61B5/0816A61B5/1116A61B5/1118A61B5/686A61B5/6869A61N1/3624A61N1/36521A61N1/36592
    • A medical device is provided that comprises a lead assembly. The lead assembly includes at least one intra-cardiac (IC) electrode, an extra-cardiac (EC) electrode and a subcutaneous remote-cardiac (RC) electrode. The IC electrode is configured to be located within the heart. The EC electrode is configured to be positioned proximate to at least one of a superior vena cava (SVC) and a left ventricle (LV) of a heart. The RC electrode is configured to be located remote from the heart. An arrhythmia monitoring module is configured to analyze intra-cardiac electrogram (IEGM) signals from the at least one IC electrode to identify a potential atrial arrhythmia. An extra-cardiac impedance (ECI) module is configured to measure extra-cardiac impedance along an ECI vector between the EC and RC electrodes to obtain ECI measurements. The hemodynamic performance (HDP) assessment module is configured to determine a hemodynamic performance based on the ECI measurements. The arrhythmia monitoring module is configured to declare the potential atrial arrhythmia to be an atrial arrhythmia based on the hemodynamic performance determined from the ECI measurements. The medical device further provides the HDP assessment module that derives a current ECI waveform from current ECI measurements and compares the current ECI pattern with a prior ECI waveform that is derived from prior ECI measurements.
    • 提供了包括引线组件的医疗装置。 引线组件包括至少一个心脏内(IC)电极,心外(EC)电极和皮下远心电(RC)电极)。 IC电极被配置为位于心脏内。 EC电极配置成靠近心脏的上腔静脉(SVC)和左心室(LV)中的至少一个定位。 RC电极被配置为远离心脏。 心律失常监测模块被配置为分析来自至少一个IC电极的心脏内电针(IEGM)信号以识别潜在的心房心律失常。 心脏外阻抗(ECI)模块被配置为测量EC和RC电极之间的ECI向量的心外阻抗,以获得ECI测量值。 血液动力学性能(HDP)评估模块被配置为基于ECI测量来确定血液动力学性能。 心律失常监测模块被配置为基于从ECI测量确定的血流动力学性能来将潜在心房心律失常宣告为心房心律失常。 医疗设备还提供HDP评估模块,其从当前ECI测量中导出当前ECI波形,并将当前ECI模式与从先前ECI测量得到的先前ECI波形进行比较。